Health ❯Healthcare ❯Clinical Trials

Phase 3 Trials

Efficacy Studies SURMOUNT-OSA AEGEAN Trial Eli Lilly Eli Lilly Trials Gilead Sciences Randomized Trials FRESCO-2 Trial BOREAS and NOTUS Circulating Tumor Cells PURPOSE 2 Trial GSK Clinical Trial SCORPIO-PEP Trial BE HEARD Studies Eosinophilic Inflammation Management ADRIATIC Trial SURMOUNT-OSA Study CagriSema E. coli Vaccine Trials STRIDE-3 Study PURPOSE 1 Trial Diazoxide Choline Extended-Release Zepbound Trial Results

EMA Rejects Eli Lilly's Alzheimer's Drug Kisunla Over Safety Concerns

FDA Approves VYKAT XR, First Therapy for Hyperphagia in Prader-Willi Syndrome

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

New Injection Shows Promise as First Major Asthma and COPD Treatment Breakthrough in 50 Years

Shionogi's COVID Pill Shows Promise in Reducing Transmission

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

RSV Vaccine Sales Decline Sharply in U.S. Amid Narrowed Eligibility

FDA Approves Regeneron-Sanofi's Dupixent for COPD Treatment

New Biannual HIV Injection Reduces Infection Risk by 96%

Weekly Insulin Shots Match Daily Injections in Diabetes Management

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

New HIV Prevention Drug Shows 100% Efficacy in Women

New HIV Prevention Shot Shows 100% Efficacy in Women